{
    "id": 22393,
    "fullName": "KMT2A - MLLT10",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "KMT2A-MLLT10 results from the fusion of KMT2A (MLL) and MLLT10 (AF10), resulting in the transformation of primitive myeloid progenitor cells in mouse models, which eventually leads to leukemogenesis (PMID: 11986236).",
            "references": [
                {
                    "id": 5484,
                    "pubMedId": 11986236,
                    "title": "The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11986236"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4297,
        "geneSymbol": "KMT2A",
        "terms": [
            "KMT2A",
            "ALL-1",
            "CXXC7",
            "HRX",
            "HTRX1",
            "MLL",
            "MLL1",
            "MLL1A",
            "TRX1",
            "WDSTS"
        ]
    },
    "variant": "KMT2A - MLLT10",
    "createDate": "05/10/2016",
    "updateDate": "01/18/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 8028,
                "geneSymbol": "MLLT10",
                "terms": [
                    "MLLT10",
                    "AF10"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 6224,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing the fusion, KMT2A-MLLT10, demonstrated sensitivity to EPZ004777 in culture and in mouse models, resulting in cell cycle arrest, increased apoptotic activity, and inhibition of cell proliferation (PMID: 23138183).",
            "molecularProfile": {
                "id": 22961,
                "profileName": "KMT2A - MLLT10"
            },
            "therapy": {
                "id": 1744,
                "therapyName": "EPZ004777",
                "synonyms": null
            },
            "indication": {
                "id": 1240,
                "name": "leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5485,
                    "pubMedId": 23138183,
                    "title": "Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23138183"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11381,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, I-BET151 and SGC0946 synergistically inhibited proliferation of patient-derived acute myeloid leukemia cells harboring KMT2A-MLLT10 in culture (PMID: 27294782).",
            "molecularProfile": {
                "id": 22961,
                "profileName": "KMT2A - MLLT10"
            },
            "therapy": {
                "id": 5966,
                "therapyName": "I-BET151 + SGC0946",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9271,
                    "pubMedId": 27294782,
                    "title": "Functional interdependence of BRD4 and DOT1L in MLL leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27294782"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 22961,
            "profileName": "KMT2A - MLLT10",
            "profileTreatmentApproaches": [
                {
                    "id": 8838,
                    "name": "DOT1L Inhibitor",
                    "profileName": "KMT2A - MLLT10"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}